{"id":"W6921073946","doi":"10.6084/m9.figshare.23060818","title":"A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; Ottawa Hospital; Queen's University","funders":"","keywords":"Carfilzomib; Thalidomide; Tolerability; Bortezomib; Adverse effect; Proteasome inhibitor; AL amyloidosis; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001080639,0.001205421,0.001680219,0.0004248565,0.0003256733,0.0007962173,0.0005138374,0.0008664049,0.002591396],"category_scores_gemma":[0.0008197798,0.0005369157,0.001146886,0.0003458279,0.0006312564,0.0005772342,0.0002329343,0.002731028,0.0006076214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000737838,"about_ca_system_score_gemma":0.0008387823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009460624,"about_ca_topic_score_gemma":0.001997642,"domain_scores_codex":[0.999627,0.000169799,0.00001911358,0.00006390343,0.00003864334,0.00008162529],"domain_scores_gemma":[0.999535,0.00008068275,0.00008754239,0.00004255159,0.00003583883,0.000218388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7161137,0.09053564,0.006101192,0.0007791311,0.001434888,0.0003376564,0.0005063167,0.002644642,0.05761484,0.0001974432,0.003138234,0.1205964],"study_design_scores_gemma":[0.5673243,0.4136035,0.01291154,0.00002322966,0.00030912,0.0002028607,0.00004584452,0.0008626337,0.002542017,0.000132119,0.002019169,0.00002373658],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952329,0.001445617,0.0002735496,0.0003334898,0.00007544151,0.001238083,0.0003521402,0.00005924957,0.0009894603],"genre_scores_gemma":[0.9936712,0.001166647,0.00101668,0.0005266966,0.00009706637,0.001061938,0.0009326298,0.00001917854,0.001508079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002591396,"threshold_uncertainty_score":0.008669078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02815233001993333,"score_gpt":0.2938618571517955,"score_spread":0.2657095271318622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}